• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症的负担:成本。

The burden of osteoporosis: cost.

作者信息

Lindsay R

机构信息

Regional Bone Center, Helen Hayes Hospital, West Haverstraw, New York 10993, USA.

出版信息

Am J Med. 1995 Feb 27;98(2A):9S-11S. doi: 10.1016/s0002-9343(05)80038-5.

DOI:10.1016/s0002-9343(05)80038-5
PMID:7709941
Abstract

Osteoporotic fractures are generally assumed to be a major public health problem in the western world. Cost calculations are based primarily on hip fractures, which are easy to count since most require hospital admission and surgical intervention. The estimates of cost, which are $10-20 billion annually in the United States to $0.3 billion in England and Wales are therefore likely to be underestimates of the total cost of the disease. As populations age throughout the world, the costs worldwide can only increase, and estimates are staggering. Within 50 years the cost of hip fracture alone in the United States may exceed $240 billion. In some countries there appears also an age-specific increase in incidence that will only compound the problem. It is not clear to what extent therapeutic interventions can control the possible epidemic of fractures in the next century.

摘要

骨质疏松性骨折通常被认为是西方世界的一个主要公共卫生问题。成本计算主要基于髋部骨折,因为大多数髋部骨折需要住院治疗和手术干预,所以很容易统计。美国每年的成本估计为100亿至200亿美元,而在英格兰和威尔士为3亿美元,因此这些估计可能低估了该疾病的总成本。随着全球人口老龄化,全球成本只会增加,而且估计数字惊人。50年内,仅美国髋部骨折的成本可能就会超过2400亿美元。在一些国家,发病率似乎也有特定年龄段的上升,这只会使问题更加复杂。目前尚不清楚治疗干预措施在下个世纪能在多大程度上控制可能出现的骨折流行。

相似文献

1
The burden of osteoporosis: cost.骨质疏松症的负担:成本。
Am J Med. 1995 Feb 27;98(2A):9S-11S. doi: 10.1016/s0002-9343(05)80038-5.
2
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.1995年美国骨质疏松性骨折治疗的医疗支出:美国国家骨质疏松基金会报告
J Bone Miner Res. 1997 Jan;12(1):24-35. doi: 10.1359/jbmr.1997.12.1.24.
3
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.2005 - 2025年美国骨质疏松症相关骨折的发病率及经济负担
J Bone Miner Res. 2007 Mar;22(3):465-75. doi: 10.1359/jbmr.061113.
4
The societal burden of osteoporosis in Sweden.瑞典骨质疏松症的社会负担。
Bone. 2007 Jun;40(6):1602-9. doi: 10.1016/j.bone.2007.02.027. Epub 2007 Mar 7.
5
Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.老年男性和女性骨质疏松性骨折的直接临床和福利成本。
Osteoporos Int. 1995;5(6):427-32. doi: 10.1007/BF01626603.
6
The burden of osteoporosis in California, 1998.1998年加利福尼亚州的骨质疏松症负担
Osteoporos Int. 2002;13(6):493-500. doi: 10.1007/s001980200060.
7
Osteoporosis: impact on health and economics.骨质疏松症:对健康和经济的影响。
Nat Rev Rheumatol. 2010 Feb;6(2):99-105. doi: 10.1038/nrrheum.2009.260.
8
Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database.2001年法国骨质疏松性骨折的发病率及费用。基于国家医院数据库的一种方法学途径。
Osteoporos Int. 2005 Dec;16(12):1475-80. doi: 10.1007/s00198-005-2031-0. Epub 2005 Oct 11.
9
Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025.估算各州人群骨质疏松症当前及未来负担的方法:应用于2000年至2025年的佛罗里达州
Value Health. 2003 Sep-Oct;6(5):574-83. doi: 10.1046/j.1524-4733.2003.65261.x.
10
Direct medical costs attributable to osteoporotic fractures.骨质疏松性骨折所致的直接医疗费用。
Osteoporos Int. 2002;13(4):323-30. doi: 10.1007/s001980200033.

引用本文的文献

1
Alendronate for Effective Treatment of Male Osteoporosis: An Insight.阿仑膦酸钠有效治疗男性骨质疏松症:见解
Curr Pharm Des. 2025;31(1):26-36. doi: 10.2174/0113816128310838240820065324.
2
Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.女性对骨质疏松症治疗的价值观和偏好:系统评价。
J Clin Endocrinol Metab. 2019 May 1;104(5):1631-1636. doi: 10.1210/jc.2019-00193.
3
A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality.
骨质疏松性骨折患者出院后结局的系统评价:发病率、后续骨折和死亡率。
Ther Clin Risk Manag. 2014 Nov 18;10:937-48. doi: 10.2147/TCRM.S72456. eCollection 2014.
4
Psychometric properties and osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M).2 型糖尿病患者的心理测量特性和护骨行为:骨质疏松自我效能量表马来语版(OSES-M)。
Osteoporos Int. 2013 Mar;24(3):929-40. doi: 10.1007/s00198-012-2071-1. Epub 2012 Jul 13.
5
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).非髋部、非脊柱骨折导致骨折后医疗利用增加:女性骨质疏松全球纵向研究(GLOW)。
Osteoporos Int. 2013 Jan;24(1):59-67. doi: 10.1007/s00198-012-1968-z. Epub 2012 Apr 12.
6
The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos).骨质疏松性骨折的负担超出急性护理范围:加拿大多中心骨质疏松症研究(CaMos)。
Age Ageing. 2011 Sep;40(5):602-7. doi: 10.1093/ageing/afr085. Epub 2011 Jul 20.
7
A fractured service: the latest advice on osteoporosis.
Br J Gen Pract. 2009 Apr;59(561):239-41. doi: 10.3399/bjgp09X420293.
8
The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis.利塞膦酸盐治疗日本骨质疏松症女性的成本效益。
J Bone Miner Metab. 2008;26(1):34-41. doi: 10.1007/s00774-007-0794-4. Epub 2008 Jan 10.
9
Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries.五个欧洲国家非椎体骨质疏松性骨折相关直接单位成本的估算。
Rheumatol Int. 2006 Oct;26(12):1063-72. doi: 10.1007/s00296-006-0180-x. Epub 2006 Sep 5.
10
Gene identification and analysis of transcripts differentially regulated in fracture healing by EST sequencing in the domestic sheep.通过对家绵羊进行EST测序来鉴定和分析骨折愈合过程中差异表达的转录本的基因
BMC Genomics. 2006 Jul 5;7:172. doi: 10.1186/1471-2164-7-172.